Walking Difficulty
51
12
15
25
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.9%
2 terminated out of 51 trials
92.6%
+6.1% vs benchmark
2%
1 trials in Phase 3/4
0%
0 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (51)
Impact of Loss Aversion Messaging and Anticipated Regret for Inaction on Exercise Adherence in Older Adults
ENhancing Exercise With LIGHT to Improve Functioning in PAD
Fisetin to Reduce Senescence and Mobility Impairment in PAD
SMART Exercise for PAD
A Motor Learning Intervention to Target Walking Performance in Ambulant Children With Cerebral Palsy
How Stroke Affects Leg Muscles When Walking
Biomarkers of Reaction To HIIT Exercise
Development and Efficacy of a Novel, Cost-Effective Gait Training Device Utilized at Home for Stroke Survivors
Testing Interventions for Mobility Through Exercise (TIME)
Chronic Wounds and Blood Circulation Detection
Reflex Excitability in Post-stroke Stiff-Knee Gait
Neurophysiological Effects of Transcutaneous Electrical Nerve Stimulation in Persons With MS
Far Red Light to Improve Functioning in PAD
To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors
Functional Activity Strength Training
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
Outcome of a Cohort of Patients Fitted With a SYME Type Prosthesis in the Context of a Hindfoot Amputation With Distal Support
Walking With the SAIRE Smart Walker
Passive Stretching in Peripheral Arterial Disease Patients
Cortical Processes During Walking Post-stroke